Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph 1 Oral LOXO-292 w/Advanced NSCLC, Medullary Thyroid Cancer, and Other Tumors w/> RET Activity

Protocol: OSU-17109

Full Title

A Phase 1 Study of Oral LOXO-292 in Adult Patients with Advanced Solid Tumors, Including RET-Fusion Non-Small Cell Lung Cancer, Medullary Thyroid Cancer, and Other Tumors with Increased RET Activity